AA
SRRA

Ancora Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Ancora Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,660
Closed -$132K – 542
2016
Q2 		$132K Buy
+1,660
New +$316K 0.02% 489

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ancora Advisors's SRRA Position: Q3 2016 in Review

Ancora Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2016, closing a stake of 1,660 shares — an estimated $132K sold.

Ancora Advisors first reported a position in SRRA in Q2 2016 and held it in 1 quarter. The position peaked at $132K in Q2 2016. 42 funds tracked by Wall St. Rank hold SRRA as of Q3 2016.

  • Ancora Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Ancora Advisors sold 1,660 Sierra Oncology, Inc. Common Stock shares in Q3 2016, an estimated $132K.
  • Ancora Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • Ancora Advisors's Sierra Oncology, Inc. Common Stock position peaked at $132K in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2016.

Based on Ancora Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.